Maximus, Inc. (NYSE:MMS – Get Free Report) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as $52.73 and last traded at $53.3310, with a volume of 272952 shares. The stock had previously closed at $54.46.
Analyst Ratings Changes
A number of brokerages have issued reports on MMS. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Maximus Stock Down 1.6%
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, topping the consensus estimate of $1.98 by $0.09. The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s revenue was down 4.1% on a year-over-year basis. During the same period in the previous year, the business earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Sell-side analysts predict that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.32 annualized dividend and a dividend yield of 2.5%. Maximus’s payout ratio is presently 19.76%.
Institutional Investors Weigh In On Maximus
Institutional investors and hedge funds have recently bought and sold shares of the stock. Farther Finance Advisors LLC grew its stake in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after buying an additional 116 shares in the last quarter. Advisory Services Network LLC bought a new stake in shares of Maximus during the 3rd quarter worth $32,000. Canada Pension Plan Investment Board bought a new stake in shares of Maximus during the 2nd quarter worth $35,000. Northwestern Mutual Wealth Management Co. grew its position in Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after acquiring an additional 304 shares in the last quarter. Finally, Richardson Financial Services Inc. raised its holdings in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after buying an additional 103 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- Rocket Lab Defies Gravity With $8B Buyout
- Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks
- The Quantum Bubble Is Real Enough to Take Seriously
- Why Wall Street Still Sees Massive Upside for AeroVironment Stock
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
